| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
88 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2025 | THC Tenet Healthcare Corp | Sutaria Saumya | CEO | Sell | 59,456 | $190.48 | $11,325,178.88 | -13.3% | - | - | |
| Sep 10, 2025 | ALHC Alignment Healthcare, Inc. | Kao John E | Chief Executive Officer | Sell | 535,018 | $16.41 | $8,779,960.71 | -4.9% | +16.8% | - | |
| Sep 10, 2025 | ALHC Alignment Healthcare, Inc. | Joyce Christopher J | Chief Legal And Admin. Officer | Sell | 8,811 | $16.86 | $148,513.81 | -2.5% | +16.8% | - | |
| Sep 10, 2025 | ALHC Alignment Healthcare, Inc. | Maroney Dawn Christine | President | Sell | 77,555 | $16.23 | $1,258,663.36 | -3.9% | +16.8% | - | |
| Sep 10, 2025 | CCEL Cryo Cell International Inc | Portnoy David | Chairman, Co-ceo | Buy | 42,900 | $4.43 | $189,985.84 | +2.2% | -3.5% | - | |
| Sep 9, 2025 | CHE Chemed Corp | Grace Patrick P | Director | Sell | 150 | $463.39 | $69,508.50 | -4.2% | - | - | |
| Sep 9, 2025 | OPCH Option Care Health, Inc. | Wright Norman L. | Director | Buy | 3,411 | $29.31 | $99,976.07 | +28.2% | - | - | |
| Sep 9, 2025 | ALHC Alignment Healthcare, Inc. | Konowiecki Joseph S | Director | Sell | 25,000 | $17.00 | $425,000.00 | -2.2% | +17.5% | - | |
| Sep 8, 2025 | HCA Hca Healthcare, Inc. | Cuffe Michael S. | EVP And Chief Clinical Officer | Sell | 3,836 | $418.84 | $1,606,670.24 | -10.9% | - | - | |
| Sep 5, 2025 | USPH U S Physical Therapy Inc /nv | Williams Eric Joseph | President And COO | Sell | 1,000 | $85.25 | $85,250.00 | -3.8% | - | - | |
| Sep 4, 2025 | TOI Oncology Institute, Inc. | M33 Growth I L.P. | Director, 10% Owner | Sell | 6,700,000 | $3.09 | $20,703,000.00 | -44.0% | - | - | |
| Sep 4, 2025 | USPH U S Physical Therapy Inc /nv | Reading Christopher J | Chairman Of The Board And CEO | Sell | 2,000 | $83.53 | $167,060.00 | -1.7% | - | - | |
| Sep 4, 2025 | SGRY Surgery Partners, Inc. | Bane Harrison R. | National Group President | Sell | 5,726 | $22.48 | $128,720.48 | -4.5% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.